J. Goldman & Co’s Axonics, Inc. Common Stock AXNX Stock Holding History

J. Goldman & Co’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-71,442	Closed	-$2.51M	–	407
2020 Q2	$2.51M	Buy	+71,442	New	+$2.46M	0.16%	144
2020 Q1	–	Sell	-403,027	Closed	-$11.2M	–	362
2019 Q4	$11.2M	Buy	403,027 +332,750	+473%	+$7.94M	0.8%	31
2019 Q3	$1.89M	Buy	+70,277	New	+$2.45M	0.14%	161

Other funds holding AXNX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

J. Goldman & Co's AXNX Position: Q3 2020 in Review

J. Goldman & Co sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2020, closing a stake of 71,442 shares — an estimated $2.51M sold.

J. Goldman & Co first reported a position in AXNX in Q3 2019 and held it in 3 quarters. The position peaked at $11.2M in Q4 2019. 151 funds tracked by Wall St. Rank hold AXNX as of Q3 2020.

J. Goldman & Co reported no remaining Axonics, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
J. Goldman & Co sold 71,442 Axonics, Inc. Common Stock shares in Q3 2020, an estimated $2.51M.
J. Goldman & Co first reported a position in Axonics, Inc. Common Stock in Q3 2019 and held it in 3 quarters.
J. Goldman & Co's Axonics, Inc. Common Stock position peaked at $11.2M in Q4 2019.
151 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2020.

Based on J. Goldman & Co's 13F filing for Q3 2020, filed 16 Nov 2020.